Conditions federal funding to bar or restrict gender‑transition medical and surgical treatments for minors, requires parental notice/consent, and creates private lawsuits and provider conscience protections.
Official title: To prohibit Federal funds from being used for sex-trait altering treatments for minors, and for other purposes.
Introduced March 26, 2025 by Robert F. Onder · Last progress March 26, 2025
The bill shifts decision‑making power and legal protections toward parents and objecting providers and blocks federal support for sex‑trait altering treatments for minors—strengthening parental rights and plaintiff remedies while substantially reducing access to care for transgender youth and increasing litigation, funding, and operational risks for providers, states, and federal programs.
Parents of minors gain required notice, counseling, and written consent before schools or health providers facilitate sex‑trait altering treatments for their children, preserving parental decision‑making.
Harmed minors (and their parents) have stronger civil remedies: extended statute-of-limitations (up to 30 years after majority), fee-shifting, and enhanced damages available to plaintiffs.
Health care workers and institutions that object to performing or covering sex‑trait altering treatments receive explicit protections from employer or government punishment and a private right to sue for injunctive or compensatory relief.
Children and adolescents who seek gender‑affirming care will face reduced access to federally funded or affiliated treatments and programs, limiting medically recommended options for transgender youth.
Providers, hospitals, schools, and clinics will likely be chilled from offering or supporting gender‑affirming care for minors due to criminal, civil, and funding risks, further shrinking available care and specialists.
The bill substantially increases litigation exposure (private suits vs. agencies, treble damages, long filing windows) for federal agencies, states, providers, and insurers, creating higher legal costs, insurance premiums, and fiscal uncertainty.
Based on analysis of 11 sections of legislative text.
Prohibits federal funds from supporting or promoting gender‑transition medical and surgical treatments for minors in schools, health care settings, and federally funded institutions unless parents are notified and give written consent. It creates broad private rights of action allowing parents, minors, taxpayers, and providers to sue federal agencies, states, providers, and institutions that violate the restrictions, and it shields providers who decline to participate from federal penalties or state requirements to provide such care. The bill defines "sex‑trait altering treatment" (including puberty blockers, cross‑sex hormones, and many gender‑reassignment surgeries), exempts certain emergency and disorder‑of‑sex‑development care, conditions federal funding on state policies that respect parental refusal, and extends long statutes of limitations (up to 30 years after majority) for civil suits by harmed minors, parents, taxpayers, and providers.